Publication:
Nonscarring alopecia in systemic lupus erythematosus: A cross-sectional study with trichoscopic, histopathologic, and immunopathologic analyses

dc.contributor.authorKumutnart Chanprapaphen_US
dc.contributor.authorSiriorn Udompanichen_US
dc.contributor.authorYingluck Visessirien_US
dc.contributor.authorPintip Ngamjanyapornen_US
dc.contributor.authorPoonkiat Suchonwaniten_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.date.accessioned2020-01-27T09:17:59Z
dc.date.available2020-01-27T09:17:59Z
dc.date.issued2019-12-01en_US
dc.description.abstract© 2019 American Academy of Dermatology, Inc. Background: Nonscarring alopecia in systemic lupus erythematosus (SLE) is widely recognized, but reports on its clinical, trichoscopic, histopathologic, and direct immunofluorescence (DIF) features are still limited. Objective: To summarize the different clinical patterns, trichoscopic, histopathologic, and DIF features of nonscarring alopecia in SLE and to prove its association with disease activity. Methods: Patients with SLE with and without nonscarring alopecia had full physical/trichoscopic examination and scalp biopsy. Their disease activity scores and laboratory data were evaluated and statistically analyzed. Results: Thirty-two patients with SLE had different patterns of nonscarring alopecia, including mild diffuse alopecia (43.8% [n = 14]), severe diffuse alopecia (15.6% [n = 5]), patchy alopecia (28.1% [n = 9]), and lupus hair (12.5% [n = 4]). The most common trichoscopic findings were arborizing/interconnecting vessels (83% [n = 26]). Histopathologic examination showed interface changes along the dermoepidermal junction (87.5% [n = 28]) and follicular epithelium (40.6% [n = 13]). On DIF, homogeneous granular deposition was detected along the dermoepidermal junction (78.1% [n = 25]) and follicular epithelium (78.1% [n = 25]). When compared with 10 patients with SLE without alopecia, there was a significantly higher SLE Disease Activity Index 2000 score and prevalence of proteinuria (>1 g/d). Limitations: This was a small, cross-sectional, single-center study. Conclusions: Nonscarring alopecia in SLE shows lupus erythematosus–specific changes on histology and DIF. Hair loss in SLE can be considered as an indicator of active disease.en_US
dc.identifier.citationJournal of the American Academy of Dermatology. Vol.81, No.6 (2019), 1319-1329en_US
dc.identifier.doi10.1016/j.jaad.2019.05.053en_US
dc.identifier.issn10976787en_US
dc.identifier.issn01909622en_US
dc.identifier.other2-s2.0-85073164091en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/51257
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073164091&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleNonscarring alopecia in systemic lupus erythematosus: A cross-sectional study with trichoscopic, histopathologic, and immunopathologic analysesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073164091&origin=inwarden_US

Files

Collections